Marcas L - Search Results

Year	Number of Results
1998	1
2004	1
2006	1
2007	1
2008	1
2009	1
2010	2
2012	1
2022	2
2023	1
2024	0

1

Autosomal dominant polycystic kidney disease in young adults.

Martínez V, Furlano M, Sans L, Pulido L, García R, Pérez-Gómez MV, Sánchez-Rodríguez J, Blasco M, Castro-Alonso C, Fernández-Fresnedo G, Robles NR, Valenzuela MP, Naranjo J, Martín N, Pilco M, Agraz-Pamplona I, González-Rodríguez JD, Panizo N, Fraga G, Fernández L, López MT, Dall'Anese C, Ortiz A, Torra R; participants in the REPQRAD. Martínez V, et al. Clin Kidney J. 2022 Nov 29;16(6):985-995. doi: 10.1093/ckj/sfac251. eCollection 2023 Jun. Clin Kidney J. 2022. PMID: 37260991 Free PMC article.

2

Measuring synaptic transmission and plasticity with fEPSP recordings in behaving mice.

Heim LR, Shoob S, de Marcas L, Zarhin D, Slutsky I. Heim LR, et al. Among authors: de marcas l. STAR Protoc. 2022 Jan 20;3(1):101115. doi: 10.1016/j.xpro.2021.101115. eCollection 2022 Mar 18. STAR Protoc. 2022. PMID: 35118427 Free PMC article.

3

Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study.

Pérez-García R, Martín-Malo A, Fort J, Cuevas X, Lladós F, Lozano J, García F; ANSWER study. Pérez-García R, et al. Nephrol Dial Transplant. 2009 Feb;24(2):578-88. doi: 10.1093/ndt/gfn464. Epub 2008 Nov 21. Nephrol Dial Transplant. 2009. PMID: 19028750 Free PMC article.

4

Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.

Marsillach J, Martínez-Vea A, Marcas L, Mackness B, Mackness M, Ferré N, Joven J, Camps J. Marsillach J, et al. Among authors: marcas l. Clin Exp Pharmacol Physiol. 2007 Apr;34(4):347-9. doi: 10.1111/j.1440-1681.2007.04552.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17324148 Clinical Trial.

5

Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease.

Martinez-Vea A, Marcas L, Bardají A, Romeu M, Gutierrez C, García C, Compte T, Nogues R, Peralta C, Giralt M. Martinez-Vea A, et al. Among authors: marcas l. Clin Nephrol. 2012 Mar;77(3):171-81. doi: 10.5414/cn107309. Clin Nephrol. 2012. PMID: 22377247

6

Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.

Fort J, Cuevas X, García F, Pérez-García R, Lladós F, Lozano J, Martín-Malo A; ANSWER study. Fort J, et al. Nephrol Dial Transplant. 2010 Aug;25(8):2702-10. doi: 10.1093/ndt/gfq073. Epub 2010 Feb 22. Nephrol Dial Transplant. 2010. PMID: 20176608

7

Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state.

Martinez-Vea A, Bardaj A, Gutierrez C, Garca C, Peralta C, Marcas L, Oliver JA. Martinez-Vea A, et al. Among authors: marcas l. Am J Kidney Dis. 2004 Aug;44(2):216-23. doi: 10.1053/j.ajkd.2004.04.026. Am J Kidney Dis. 2004. PMID: 15264179

8

Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study.

Romeu M, Nogues R, Marcas L, Sánchez-Martos V, Mulero M, Martinez-Vea A, Mallol J, Giralt M. Romeu M, et al. Among authors: marcas l. BMC Res Notes. 2010 Jan 25;3:20. doi: 10.1186/1756-0500-3-20. BMC Res Notes. 2010. PMID: 20181004 Free PMC article.

9

Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.

Martinez-Vea A, Salvadó E, Bardají A, Gutierrez C, Ramos A, García C, Compte T, Peralta C, Broch M, Pastor R, Angelet P, Marcas L, Saurí A, Oliver JA. Martinez-Vea A, et al. Among authors: marcas l. Am J Kidney Dis. 2006 Feb;47(2):241-50. doi: 10.1053/j.ajkd.2005.10.029. Am J Kidney Dis. 2006. PMID: 16431253

10

Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.

Puig JM, Lloveras J, Fernández-Crespo P, Mir M, Marcas LI, Manresa JM, Masramón J. Puig JM, et al. Among authors: marcas li. Transplant Proc. 1998 Aug;30(5):2226-7. doi: 10.1016/s0041-1345(98)00598-3. Transplant Proc. 1998. PMID: 9723449 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year